In the present investigation, we chose to analyse serum IL-6 because, in CRC patients, IL-6 has been shown directly linked to the clinical presentation of the systemic inflammatory response, such as skeletal muscle wasting under metabolic malfunctioning [49]. This evidence concerns the gene IL6 and colorectal carcinoma.